Paragon Care (PGC) Stock Overview
Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
PGC Community Fair Values
Create NarrativeSee what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Paragon Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.15 |
| 52 Week High | AU$0.41 |
| 52 Week Low | AU$0.14 |
| Beta | -0.32 |
| 1 Month Change | 7.14% |
| 3 Month Change | -14.29% |
| 1 Year Change | -62.50% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -61.54% |
Recent News & Updates
PGC: Steady Assumptions And Lower Multiple Will Support Future Share Upside
Analysts have trimmed their fair value estimate for Paragon Care from A$0.32 to A$0.25, reflecting updated assumptions around profit margins and a lower future P/E multiple, while keeping other key inputs broadly unchanged. What's in the News No recent company-specific news, periodical coverage, or key developments were provided for Paragon Care.
Integration Risks And Asia Medtech Execution Will Shape Fairly Valued Outlook
Catalysts About Paragon Care Paragon Care operates healthcare distribution, MedTech and contract logistics businesses across Australia, New Zealand and several Asian markets. What are the underlying business or industry changes driving this perspective?PGC: Index Inclusion And Steady Assumptions Will Support Future Share Upside
Analysts have maintained their A$0.32 fair value estimate for Paragon Care, reflecting stable assumptions on the discount rate, revenue growth, profit margin, and future P/E, which together support a consistent view of the stock’s medium-term earnings power. What's in the News Paragon Care Limited was added to the S&P/ASX Emerging Companies Index, putting the stock on the radar of investors who follow index-linked products and benchmarks (Key Developments).PGC: Index Addition And Stable Assumptions Will Support Future Share Upside
Paragon Care’s analyst price target remains at A$0.315. Analysts point to only minor tweaks in inputs such as the discount rate and assumed future P/E as the basis for leaving their valuation unchanged.PGC: Index Inclusion And Stable Assumptions Will Support Future Share Upside
Analysts have kept their A$0.32 fair value estimate for Paragon Care unchanged, citing stable assumptions on discount rate, revenue growth, profit margin and future P/E, which together support a steady price target outlook. What's in the News Paragon Care Limited was added to the S&P/ASX Emerging Companies Index, highlighting its inclusion in a broader benchmark universe (Key Developments).Recent updates
PGC: Steady Assumptions And Lower Multiple Will Support Future Share Upside
Analysts have trimmed their fair value estimate for Paragon Care from A$0.32 to A$0.25, reflecting updated assumptions around profit margins and a lower future P/E multiple, while keeping other key inputs broadly unchanged. What's in the News No recent company-specific news, periodical coverage, or key developments were provided for Paragon Care.Integration Risks And Asia Medtech Execution Will Shape Fairly Valued Outlook
Catalysts About Paragon Care Paragon Care operates healthcare distribution, MedTech and contract logistics businesses across Australia, New Zealand and several Asian markets. What are the underlying business or industry changes driving this perspective?PGC: Index Inclusion And Steady Assumptions Will Support Future Share Upside
Analysts have maintained their A$0.32 fair value estimate for Paragon Care, reflecting stable assumptions on the discount rate, revenue growth, profit margin, and future P/E, which together support a consistent view of the stock’s medium-term earnings power. What's in the News Paragon Care Limited was added to the S&P/ASX Emerging Companies Index, putting the stock on the radar of investors who follow index-linked products and benchmarks (Key Developments).PGC: Index Addition And Stable Assumptions Will Support Future Share Upside
Paragon Care’s analyst price target remains at A$0.315. Analysts point to only minor tweaks in inputs such as the discount rate and assumed future P/E as the basis for leaving their valuation unchanged.PGC: Index Inclusion And Stable Assumptions Will Support Future Share Upside
Analysts have kept their A$0.32 fair value estimate for Paragon Care unchanged, citing stable assumptions on discount rate, revenue growth, profit margin and future P/E, which together support a steady price target outlook. What's in the News Paragon Care Limited was added to the S&P/ASX Emerging Companies Index, highlighting its inclusion in a broader benchmark universe (Key Developments).PGC: Ramsay Exit And Index Inclusion Will Support Future Earnings Upside
Analysts have lifted Paragon Care's fair value estimate slightly from A$0.31 to A$0.315, reflecting updated assumptions around revenue growth, profit margins, and a higher future P/E multiple. What's in the News Paragon Care is being added to the S&P/ASX Emerging Companies Index, increasing its visibility among index-tracking investors and funds (Index Constituent Adds).PGC: Ramsay Exit And Index Inclusion Will Support Future Margin Upside
Analysts have trimmed Paragon Care's fair value estimate slightly from A$0.32 to A$0.31. This reflects updated assumptions on future P/E and profitability while core discount rate and growth inputs remain broadly unchanged.PGC: Exit From Low Margin Contract Will Support Future Margin Upside
Analysts have trimmed their Paragon Care fair value estimate from A$0.40 to A$0.32. This reflects updated assumptions for more moderate revenue growth, a higher profit margin outlook and a lower future P/E multiple.PGC: Exit From Ramsay Pharmacy Business Will Unlock Future Value
Narrative Update on Paragon Care Analysts have trimmed their fair value estimate for Paragon Care from A$0.49 to A$0.40 as they now apply a slightly higher discount rate and assume more moderate revenue growth, profit margins and a lower future P/E multiple. What's in the News Paragon Care confirmed earnings guidance for full year 2026, with revenue expected in the range of $3.6b to $3.7b (company guidance).
Asia Medtech Expansion And Contract Logistics Scale Will Transform Long Term Earnings Quality
Catalysts About Paragon Care Paragon Care is a healthcare company focused on pharmacy wholesale, MedTech and contract logistics across Australia, New Zealand and Asia. What are the underlying business or industry changes driving this perspective?Market Cool On Paragon Care Limited's (ASX:PGC) Earnings Pushing Shares 28% Lower
Paragon Care Limited ( ASX:PGC ) shareholders that were waiting for something to happen have been dealt a blow with a...Asia Pacific Expansion And Healthcare Diversification Will Drive Future Success
Despite improved revenue growth forecasts and a lower future P/E ratio, analysts have reduced Paragon Care’s consensus price target from A$0.515 to A$0.485. What's in the News Full year 2026 revenue expected to remain at 2025 trend growth rates.Asia Pacific Expansion And Healthcare Diversification Will Drive Future Success
Key Takeaways Expansion into high-growth Asia-Pacific markets and targeting demographic-driven healthcare demand are expected to drive sustainable long-term revenue and margin growth. Acquisitions integration, investment in higher-margin areas, and improved cost structures are set to enhance profitability and operational efficiency.Paragon Care Limited's (ASX:PGC) Share Price Matching Investor Opinion
Paragon Care Limited's ( ASX:PGC ) price-to-earnings (or "P/E") ratio of 27.4x might make it look like a sell right now...Paragon Care Limited (ASX:PGC) Shares Could Be 23% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Paragon Care fair value estimate is AU$0.44 Paragon Care's...A Look At The Fair Value Of Paragon Care Limited (ASX:PGC)
Key Insights Paragon Care's estimated fair value is AU$0.42 based on 2 Stage Free Cash Flow to Equity With AU$0.45...Paragon Care's (ASX:PGC) Soft Earnings Are Actually Better Than They Appear
Paragon Care Limited's ( ASX:PGC ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...Shareholder Returns
| PGC | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -1.7% |
| 1Y | -62.5% | -13.9% | -0.01% |
Return vs Industry: PGC underperformed the Australian Healthcare industry which returned -11.6% over the past year.
Return vs Market: PGC underperformed the Australian Market which returned -0.4% over the past year.
Price Volatility
| PGC volatility | |
|---|---|
| PGC Average Weekly Movement | 9.1% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 10.1% |
| 10% most volatile stocks in AU Market | 17.1% |
| 10% least volatile stocks in AU Market | 4.1% |
Stable Share Price: PGC has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: PGC's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Carmen Riley | www.paragoncare.com.au |
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems.
Paragon Care Limited Fundamentals Summary
| PGC fundamental statistics | |
|---|---|
| Market cap | AU$248.30m |
| Earnings (TTM) | -AU$13.93m |
| Revenue (TTM) | AU$3.67b |
Is PGC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PGC income statement (TTM) | |
|---|---|
| Revenue | AU$3.67b |
| Cost of Revenue | AU$3.33b |
| Gross Profit | AU$334.44m |
| Other Expenses | AU$348.37m |
| Earnings | -AU$13.93m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0084 |
| Gross Margin | 9.12% |
| Net Profit Margin | -0.38% |
| Debt/Equity Ratio | 104.0% |
How did PGC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/10 02:32 |
| End of Day Share Price | 2026/06/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Paragon Care Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | Bell Potter |
| Thomas Godfrey | Ord Minnett Limited |